Fennec Pharma, Inc. (Fennec)

Oncology Corporate Profile

HQ Location

PO Box 13628
68 TW Alexander Drive
Research Triangle Park, NC 27709

Company Description

Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.

Website: http://fennecpharma.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
eniluracidihydropyrimidine dehydrogenase (DPD) inhibitorBreast cancerII
eniluracidihydropyrimidine dehydrogenase (DPD) inhibitorColorectal cancerI

View additional information on product candidates here »

Pipeline image

Source


http://fennecpharma.com

Recent News Headlines

There are no news items to display